nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinib
|
Mathew, Paul |
|
2011 |
68 |
4 |
p. 889-896 |
artikel |
2 |
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer
|
Ahmed, Ahmed Ashour |
|
2011 |
68 |
4 |
p. 1033-1044 |
artikel |
3 |
Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer
|
Park, Jin Hyun |
|
2011 |
68 |
4 |
p. 1045-1055 |
artikel |
4 |
A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer
|
Choi, Yoon Hee |
|
2011 |
68 |
4 |
p. 905-912 |
artikel |
5 |
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors
|
Ricart, Alejandro D. |
|
2011 |
68 |
4 |
p. 959-970 |
artikel |
6 |
A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models
|
Koo, Dong Hoe |
|
2011 |
68 |
4 |
p. 913-921 |
artikel |
7 |
Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial
|
Murialdo, R. |
|
2011 |
68 |
4 |
p. 1009-1016 |
artikel |
8 |
Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan
|
Liu, Xin |
|
2011 |
68 |
4 |
p. 871-878 |
artikel |
9 |
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
|
Stathopoulos, G. P. |
|
2011 |
68 |
4 |
p. 945-950 |
artikel |
10 |
Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients
|
Hwang, I. G. |
|
2011 |
68 |
4 |
p. 935-944 |
artikel |
11 |
Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma
|
Mori, Makiko |
|
2011 |
68 |
4 |
p. 855-862 |
artikel |
12 |
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
|
Togashi, Yosuke |
|
2011 |
68 |
4 |
p. 1089-1092 |
artikel |
13 |
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting
|
Lim, Kyu-Hyoung |
|
2011 |
68 |
4 |
p. 1017-1026 |
artikel |
14 |
Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancer
|
Shah, Dhaval K. |
|
2011 |
68 |
4 |
p. 951-958 |
artikel |
15 |
Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma
|
Lima Lopes, Gilberto de |
|
2011 |
68 |
4 |
p. 1067-1073 |
artikel |
16 |
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group
|
Yoon, H. H. |
|
2011 |
68 |
4 |
p. 863-870 |
artikel |
17 |
Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro
|
Weiss, Johanna |
|
2011 |
68 |
4 |
p. 1093-1098 |
artikel |
18 |
Interactions of bexarotene (LGD1069, Targretin) with the coagulation system
|
Hespel, Anne |
|
2011 |
68 |
4 |
p. 847-854 |
artikel |
19 |
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™)
|
Canta, A. |
|
2011 |
68 |
4 |
p. 1001-1008 |
artikel |
20 |
Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model
|
Wu, Hongju |
|
2011 |
68 |
4 |
p. 879-887 |
artikel |
21 |
Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer
|
Fernandes, Bruno José Dumêt |
|
2011 |
68 |
4 |
p. 897-904 |
artikel |
22 |
Phase I clinical and pharmacokinetic study of UTD1, a genetically engineered epothilone analog in patients with advanced solid tumors
|
Zhang, Pin |
|
2011 |
68 |
4 |
p. 971-978 |
artikel |
23 |
Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma
|
Eroglu, Zeynep |
|
2011 |
68 |
4 |
p. 1081-1087 |
artikel |
24 |
Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer
|
Zhou, Zheng-tao |
|
2011 |
68 |
4 |
p. 1027-1032 |
artikel |
25 |
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL
|
Reagan, John L. |
|
2011 |
68 |
4 |
p. 1075-1080 |
artikel |
26 |
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
|
Minturn, Jane E. |
|
2011 |
68 |
4 |
p. 1057-1065 |
artikel |
27 |
Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial
|
Cianfrocca, Mary |
|
2010 |
68 |
4 |
p. 827-833 |
artikel |
28 |
Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
|
Chon, Hong Jae |
|
2011 |
68 |
4 |
p. 991-999 |
artikel |
29 |
SCH 1473759, a novel Aurora inhibitor, demonstrates enhanced anti-tumor activity in combination with taxanes and KSP inhibitors
|
Basso, Andrea D. |
|
2011 |
68 |
4 |
p. 923-933 |
artikel |
30 |
Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin
|
Kanatani, Isao |
|
2011 |
68 |
4 |
p. 979-990 |
artikel |
31 |
Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63
|
Chow, Shu-Er |
|
2011 |
68 |
4 |
p. 835-845 |
artikel |